I
Indravadan Patel
Researcher at Brigham and Women's Hospital
Publications - 2
Citations - 3
Indravadan Patel is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Framingham Risk Score & Warfarin. The author has an hindex of 1, co-authored 2 publications receiving 3 citations.
Papers
More filters
Journal ArticleDOI
Relationship between dose, anti-factor xa activity, and outcomes in patients randomized to edoxaban in the engage af-timi 48 trial
Christian T. Ruff,Robert P. Giugliano,Eugene Braunwald,David A. Morrow,Sabina A. Murphy,Naveen Deenadayalu,Petr Jarolim,Joshua Betcher,Minggao Shi,Karen Brown,Indravadan Patel,Michele Mercuri,Elliott M. Antman +12 more
TL;DR: High (HD) and low doses (LD) of the FXa inhibitor edoxaban (edox) were noninferior to warfarin in preventing stroke/systemic embolism (stroke/SEE) with less bleeding in the ENGAGE-AF trial.
Journal ArticleDOI
Cardiac structure and function and chads2 risk score in patients with atrial fibrillation: the effects anticoagulation with factor xa next generation in afthrombolysis in myocardial infarction 48 (engage af -timi 48) echocardiographic study
Deepak K. Gupta,Amil M. Shah,Robert P. Giugliano,Christian T. Ruff,Elliott M. Antman,Laura T. Grip,Naveen Deenadayalu,Elaine B. Hoffman,Joshua Betcher,Indravadan Patel,Minggao Shi,Eugene Braunwald,Scott D. Solomon +12 more